Injectable Drugs Market Outlook 2024: Global Opportunity And Demand Analysis, Market Forecast, 2016-2024

1
Global America Injectable drugs Market Outlook
Global America injectable drugs Market Outlook
2024 Global Opportunity Growth Analysis,
2016-2024
Report Code HC 1324
1-646-568-7747
1-437-886-1181
44-203-318-6627
91-120-473-0422, 91-991-071-6331
sales_at_goldsteinresearch.com
Published By Goldstein Research
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
2
Global America Injectable drugs Market Outlook
Global America injectable drugs Market Size USD
(Billion). 2016-2024
Global America injectable drugs Market Share
(), By Countries -2016-2024
Sample Report
Sample
Source Goldstein Research
Source Goldstein Research
With XX share by 2024, United States will
dominate the Global America injectable drugs
Market
In 2016, Complex Biologics accounted for the
highest market share XX in Global America
injectable drugs Market
Global America injectable drugs Market Share (),
By Product Type-2016
Global America injectable drugs Market Share (),
By Application -2016
Source Goldstein Research
Source Goldstein Research
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
3
Global America injectable drugs Market Outlook

• Global America injectable drugs market is
  anticipated to reach USD XX billion by 2024 from
  value USD XX billion in 2016, growing at a CAGR
  of XX during the forecast period of 2016 to 2024
  owing to rising number of patients affected with
  chronic disease such as cancer and diabetes
• On the basis of market players, in the US, Pfizer
  leads in sales revenues of about USD XX billion
  USD in 2013 while Johnson Johnson realized a
  revenue of USD XX million USD in 2015. In
  Switzerland, Novartis made USD XX million in
  revenues in 2014 while Roche realized USD XX
  million USD in the same year. In France, Sanofi
  made USD XX million USD in 2014 while in Japan,
  Takeda made USD XX million USD in 2014. Bayer in
  Germany made USD XX million USD in 2014 in
  pharmaceuticals.
• In North America, the most vibrant domestic
  pharmaceutical market would be found and
  represents a burgeoning local pharma production
  industry owing to a protectionist regime as yet.
  But despite the flourish in local production, the
  rising consumer demand has led to increasing
  multinational pharma firms interest. Here, the
  regulatory environment is typified by tough entry
  barriers largely to protect local industry, price
  controls, parallel imports and the constant
  impact of fluctuations in economic conditions
• Although much effort has been put into making
  injectable drug delivery a better experience for
  patients, the problem remains that most devices
  are unable to deliver the drug to just the
  targeted organ and not throughout the whole body.
  BeloGal, a latest technology which allows drugs
  to be delivered in high doses to the right organ
  and avoids the problems of low water solubility
  that hamper many modern formulations
• The drug delivery industry is focused on finding
  ways to enhance the injection experience, i.e.
  make it more pleasant for the patient, from
  helpful reminders, self-use devices, connecting
  to smartphones, making the syringes larger or
  smaller and containers gentler and smarter.

Healthcare services shifts from clinical settings
to the home
Medical benefits and reimbursement policies
Sample
Rise in diabetic population
Advancement in pharmaceuticals cost containment
Global America injectable drugs Market Size (USD
Billion), By Country, 2016-2024
Year
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
4
Global America injectable drugs Market Outlook
2016-2024
Global America injectable drugs Y-O-Y Growth ()
Analysis-2016-2024
Global America injectable drugs Market Size (USD
Billion)-2016-2024
Sample Report
Sample
Source Goldstein Research
Source Goldstein Research
Table.1. Global Sales (USD Billion) of
Injectable Drugs, By Product Type, 2016-2024
Product Type/Year 2016 2017 2018 2019 2020 2021 2022 2023 2024 CAGR
Vaccines XX XX XX XX XX XX XX XX XX XX
Insulin XX XX XX XX XX XX XX XX XX XX
Conventional Therapeutics XX XX XX XX XX XX XX XX XX XX
Complex Biologics XX XX XX XX XX XX XX XX XX XX
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
5
Fertile Market of Sterile Injectables
Sterile Biologics Market Share (), By Type, 2016
The global sterile Injectable market is USD XX
billion in 2016 and is projected to reach USD XX
billion by 2024. The two largest segments are
Biologics (XX share) and Small Molecule
injectables (XX share), with a CAGR of XX for
the latter. Within Biologics, monoclonal
antibodies (mAbs) account for the largest market
share, followed by vaccines and insulin. In the
Small Molecule segment, Oncology and
Anti-Infectives are the major contributors of the
market.
Sample
Source Goldstein Research
What Is Driving Sterile Injectables Market?
Approximately XX injectable products are
currently in the development pipeline (potent and
non-potent), leading to growth on the innovative
side of the market. Demand for cutting edge
injectable capabilities should grow as ADCs and
other high value products dominate the potent
development space. Nevertheless, the primary
driver behind the growth in injectables is the
generic market. Growth in the generic injectables
is outpacing growth on the innovator side The
global, generic, sterile injectables market is
projected to grow from USD XX billion in 2016 to
USD XX billion in 2024 at a growth rate of XX.
Global America injectable drugs Market
Demand-supply Equation
The development and manufacturing of sterile
injectable products is both, complex, and capital
intensive. Operational costs are high since
injectables are toxic and infectious in their
natural state and hence require a higher degree
of quality and care in their manufacturing,
packaging, storage, and distribution. Stringent
regulations from FDA on manufacturing sites, pose
a major challenge for both existing players, and
for potential new market entrants.
Source Goldstein Research
Competition from low cost manufacturing zones
like India and China in the generic market has
led to discontinuation of many products in the
segment for economies of scale. Consolidation of
captive/in-house manufacturing capacities have
resulted in closure of many sterile manufacturing
sites in the US and elsewhere which, in turn has
led to product shortages in the US.
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
6
Global America injectable drugs Market Share, By
Product Type, 2016-2024

• US Injectable Drugs market accounted for USD XX
  billion in 2016 which tends to increase at a CAGR
  of XX over the forecast years and reach the
  valuation of USD XX billion by 2024
• The increase focus in biologics and targeted
  therapies, especially in the area of cancer has
  led to an increase in the need for injectable
  drugs. While biological drugs have a larger part
  of the injectable market, the small molecule
  injectable will have the higher growth
• The complex process of manufacture, high capital
  and operational costs, and the compliance
  requirements for success has led to a smaller
  number of players. These rms are being further
  reduced due to acquisitive activity in a sector
  that is rapidly consolidating. The supply crunch
  that was present a few years ago has been
  mitigated to some extent by FDA actions

Sample
Source Goldstein Research
Global America injectable drugs Market Y-O-Y
Growth, By Product Type- 2016-2024
Source Goldstein Research
Global America injectable drugs Market Size (USD
Billion), By Application-2016-2024
Source Goldstein Research
7
Global America injectable drugs Market
Attractiveness-By Country, 2016-2024
Sample Report
CAGR ()
Market Size (USD Billion)
Source Goldstein Research
Sample
According to the above graph, U.S. Injectable
Drugs market is anticipated to be the most
attractive market across all the countries in
injectable drugs market, for new entrants looking
to enter in the market, existing players looking
for business expansion and investors seeking
investment opportunities over the forecast period
i.e. 2016-2024 Canada's single-payer system is
mostly publicly funded, while the U.S. has a
multi-payer, heavily private system. While
dissatisfaction with the U.S. health care system
is widespread among Americans, Canada's health
care system enjoys high levels of satisfaction
among its own population therefore in forecast
period Canada tends to reach the considerable
market size of injectable drugs
Download Exclusive Sample Report
https//www.goldsteinresearch.com/request-sample/g
lobal-injectable-drugs-market-outlook-2024-global-
opportunity-and-demand-analysis-market-forecast-20
16-2024
Source Goldstein Research
8
Sample Report
About Us
9
About Us Based in U.S., Goldstein Research is
a young business consulting and market research
firm with vast reach across America, Asia and
parts of Europe and the Middle East. In the next
five years, we strive to expand our reach to 50
nations spanning across Europe, Asia and parts of
the Middle East and Africa. We strive to realize
a strong brand presence globally through our
quality research and forecasting solutions. With
30 domain experts and 50 employees working day
and night to crunch numbers and bring out the
best and detailed market reports and forecasts,
we strive to enable you to foresee upcoming
market challenges and develop a robust business
model and strategies, which would add to your
profitability and market visibility as a
brand. Our mission is simple to develop
insightful business solutions, help our clients
make powerful future decisions to keep them well
ahead of the game which is the market, and leave
a mark across businesses and communities through
our well-defined ideas and clear cut forecasts.
Our mission is simple to develop insightful
business solutions, help our clients make
powerful future decisions to keep them well ahead
of the game which is the market, and leave a mark
across businesses and communities through our
well-defined ideas and clear cut forecasts.
Sample Report
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
10
Contact Us For Research Sales Related Queries
Corporate Office
99 Wall Street, Suite No- 527, New York, NY
10005 United States of America
Office No- 504, 5th Floor, C-51, BSI Business
Park, Sector-62, Noida, PIN- 201301 India 
www.goldsteinresearch.com
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
11
Sample Report
Thank you